Clinical trial
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02470910
Study timeline
Study start (unknown)2015-07-01Date precision: month
Registry last updated2019-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Adenocarcinoma of the Prostate Stage Iunresolved
Adenocarcinoma of the Prostate Stage IIunresolved
Adenocarcinoma of the Prostate Stage IIIunresolved
Interventions
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02470910 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.